retatrutide parkinson's disease clinical trial drug pipeline evolution and future directions | Michael S Okun posted on the topic parkinson's disease retatrutide clinical trial

10.1016/j.rbmo.2019.04.017

Certain brain neurons and intestinal L-cells secrete this hormone after eating food

Liver fat reduced by up to 82.4%

How it works at the cellular level Unlike semaglutide, AOD 9604 does not interact with appetite centers

It occurs when excess fat builds up in the liver, which may interfere with the organs ability to: Remove toxins from the bloodstream Digest food Store and release energy Participants in early retatrutide studies also showed improvements in hemoglobin A1c (a measure of long-term blood sugar control), blood pressure, and LDL cholesterol levels as they lost weight.[7] What Are Retatrutide's Side Effects or Risks